CONTRACT PHARMACAL FDA Approval ANDA 075094

ANDA 075094

CONTRACT PHARMACAL

FDA Drug Application

Application #075094

Documents

Letter2004-06-14

Application Sponsors

ANDA 075094CONTRACT PHARMACAL

Marketing Status

Discontinued001

Application Products

001TABLET;ORALEQ 75MG BASE0RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1999-06-21
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2000-09-21

Submissions Property Types

SUPPL1Null0
SUPPL9Null0

CDER Filings

CONTRACT PHARMACAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75094
            [companyName] => CONTRACT PHARMACAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"RANITIDINE HYDROCHLORIDE","activeIngredients":"RANITIDINE HYDROCHLORIDE","strength":"EQ 75MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RANITIDINE HYDROCHLORIDE","submission":"RANITIDINE HYDROCHLORIDE","actionType":"EQ 75MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.